Patent · US Active

Neutralizing anti-influenza A antibodies and uses thereof

US11932682B2 · kind B2 · utility

0Cited by

19References

20Claims

0Family size

Assignees

MedImmune Limited · US
Humabs BioMed SA · CH

Inventors

Ebony Benjamin · Gaithersburg, US
Nicole Kallewaard-Lelay · Gaithersburg, US
Josephine Mary McAuliffe · Gaithersburg, US
Frances Palmer-Hill · Gaithersburg, US
Leslie Wachter · Gaithersburg, US
Andy Yuan · Gaithersburg, US
Qing Zhu · Mansfield Center, US
Davide Corti · Bellinzona, CH
Antonio Lanzavecchia · Bellinzona, CH
Barbara Guarino · Bellinzona, CH
Anna DeMarco · Bellinzona, CH

Key dates

Filing date	Oct 21, 2021
Grant date	Mar 19, 2024
Priority date	—
Expiry date	Oct 21, 2041

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/11
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to antibodies and binding fragments thereof that are capable of binding to influenza A virus hemagglutinin and neutralizing at least one group 1 subtype and at least 1 group 2 subtype of influenza A virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.